Dr. Elting begins this chapter by reviewing the proliferation of IRBs at MD Anderson. She discusses the reasons why they were necessary and how they have emerged as pressures on researchers were changing. She explains why the mid-nineties were a key time for rising resources to fund IRB oversight. She explains that when HIPPA went into effect, MD Anderson’s Compliance office became more concerned about adherence to proper policy. Next Dr. Elting talks about the need for IRB oversight given ethical issues that have arisen with the increase in genetic/genomic research and increases in projects involving ‘big data’ requiring that personal health information moves from institution to institution.https://openworks.mdanderson.org/mchv_intervie...
The speakers describe their experience serving on the UMass Medical School’s Institutional Review Bo...
Institutional Review Boards (IRBs) are an important checkpoint for all types of research in medicine...
On September 17, 1999, Jesse Gelsinger, an eighteen-year-old man with a rare metabolic disease, died...
Dr. Elting sketching her role in MD Anderson’s Institutional Review Boards, including establishing a...
In this chapter, Dr. Elting responds to the observation that many researchers have an adversarial vi...
Dr. Buzdar begins this chapter with an explanation of why ethical review boards (the first IRBs) wer...
Institutional Review Boards (IRBs) are the primary gatekeepers for the protection of ethical standar...
General placed institutional review boards (IRBs) under the spotlight. In its examination of clinica...
The spring and summer of 1998 were seasons in the sun for institutional review board (IRB) aficionad...
Institutional review boards (IRBs) protect the health, safety, and privacy of people participating i...
In this article, I scrutinize the process by which scientific research on humansubjects is regulated...
In this chapter, Dr. Buzdar talks about his role as Vice President of Clinical Research, an office t...
The biomedical research oversight system in the United States delegates most responsibilities to loc...
http://institutionalreviewblog.blogspot.com The main focus of the five weeks old weblog seems to be ...
Dr. Ewer begins this chapter by stressing that MD Anderson has always been interested in ‘doing the ...
The speakers describe their experience serving on the UMass Medical School’s Institutional Review Bo...
Institutional Review Boards (IRBs) are an important checkpoint for all types of research in medicine...
On September 17, 1999, Jesse Gelsinger, an eighteen-year-old man with a rare metabolic disease, died...
Dr. Elting sketching her role in MD Anderson’s Institutional Review Boards, including establishing a...
In this chapter, Dr. Elting responds to the observation that many researchers have an adversarial vi...
Dr. Buzdar begins this chapter with an explanation of why ethical review boards (the first IRBs) wer...
Institutional Review Boards (IRBs) are the primary gatekeepers for the protection of ethical standar...
General placed institutional review boards (IRBs) under the spotlight. In its examination of clinica...
The spring and summer of 1998 were seasons in the sun for institutional review board (IRB) aficionad...
Institutional review boards (IRBs) protect the health, safety, and privacy of people participating i...
In this article, I scrutinize the process by which scientific research on humansubjects is regulated...
In this chapter, Dr. Buzdar talks about his role as Vice President of Clinical Research, an office t...
The biomedical research oversight system in the United States delegates most responsibilities to loc...
http://institutionalreviewblog.blogspot.com The main focus of the five weeks old weblog seems to be ...
Dr. Ewer begins this chapter by stressing that MD Anderson has always been interested in ‘doing the ...
The speakers describe their experience serving on the UMass Medical School’s Institutional Review Bo...
Institutional Review Boards (IRBs) are an important checkpoint for all types of research in medicine...
On September 17, 1999, Jesse Gelsinger, an eighteen-year-old man with a rare metabolic disease, died...